ICON (NASDAQ:ICLR) stock fell 8% early Tuesday after it issued financial guidance for 2025. The clinical research organization said that it expects to report 2025 revenue of $8.05B to $8.650B ...

ICON plc, (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today announced its financial guidance for the year ending December 31, 2025.

The revised target comes in response to ICON's 2025 guidance, which Windley noted as being softer than expected. According to InvestingPro data, ICON's stock has experienced a significant 8.71% ...